Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

The Longs And Shorts To Watch: CALA, HDSN, CENT, IPHI

Published 07/06/2017, 12:49 AM
Updated 07/09/2023, 06:31 AM

Calithera Biosciences (NASDAQ:CALA) was up 1.85, or 12%, to 17.60, to 1.5 million shares traded on Wednesday. It broke out of a coil on Monday, followed through, tested the 17.70 area, tagged 17.90, and closed at 17.60. With nearly two days to cover , and with a strong trend, after wave one and two of wave three, I think that if it’s starting here, it will get to at least 21.00, maybe even to the mid 20’s.

It was a nice day for Hudson Technologies Inc (NASDAQ:HDSN) on Wednesday, popping 31 cents, or 4%, to 8.88, on 1.16 million shares traded. It's been up three days in a row now on pretty good volume. That’s the highest close in 20 years. The last time it saw the 900-range was back in ’97 on June 3. The volume on a monthly basis is huge. It has a breakaway gap, a wedge, multiple 5-wave moves, then a pullback on wave two, and wave 3 of 3 is starting, which could take it to the 11-12 area. It has 7.3 days to cover .

Stocks on the Short Side….

Central Garden & Pet Company (NASDAQ:CENT) was down 55 cents, or 2%, to 31.13, on 54,932 shares traded on Wednesday. The major trend channel has been broken, a bear flag formed, and it looks like it’s headed lower. If it cracks and technicals roll over, it could very well be headed for wave three that will take it down to the mid 20’s.

Inphi Corporation (NYSE:IPHI) actually gained 31 cents to 34.18, on 941,009 shares traded on Wednesday. It had a head-and-shoulder breakdown, a snap back, I gave you a short on it, it came down and bounced, formed a wedge, and now it’s coming down again and consolidating here. If this breaks 33-33 1/2, it could reach down to 30, and then 26 1/2-27.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

On the long side, stocks included Abeona Therapeutics Inc (NASDAQ:ABEO), Achillion Pharmaceuticals Inc (NASDAQ:ACHN), Advanced Micro Devices, Inc. (NASDAQ:AMD), Baozun Inc (NASDAQ:BZUN), Calithera Biosciences Inc (NASDAQ:CALA), Hudson Technologies Inc (NASDAQ:HDSN), ImmunoGen Inc (NASDAQ:IMGN), Kemet Corporation (NYSE:KEM), Direxion Daily S&P Biotech Bull 3X ETF(NYSE:LABU), Novocure Ltd (NASDAQ:NVCR), and OraSure Technologies Inc (NASDAQ:OSUR).

On the short side, stocks included AutoZone, Inc. (NYSE:AZO), Aspen Technology Inc (NASDAQ:AZPN), Central Garden & Pet Company (NASDAQ:CENT), Ebix Inc (NASDAQ:EBIX), Inphi Corporation, Kmg Chemical Inc (NYSE:KMG), PCM Inc (NASDAQ:PCMI), Parsley Energy (NYSE:PE), Ralph Lauren Corporation (NYSE:RL), Shopify Inc (NYSE:SHOP), Simon Property Group, Inc. (NYSE:SPG), Veritiv (NYSE:VRTV), and Yelp Inc (NYSE:YELP).

Latest comments

Nvcr looks very good for long
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.